NVIDIA Director’s 10b5-1 Plan Triggers 148,402-Share Sale
Filing Impact
Filing Sentiment
Form Type
4
Rhea-AI Filing Summary
Form 4 Overview – NVIDIA Corporation (NVDA)
Director A. Brooke Seawell reported a series of open-market sales executed between 8 July 2025 and 10 July 2025 under a pre-arranged Rule 10b5-1 trading plan adopted on 19 March 2025 to meet estate-tax obligations.
- Total shares sold: 148,402 common shares across eight separate transactions.
- Price range: $158.480 – $164.390; weighted-average prices per line item run from $159.0372 to $164.2981.
- Largest single sale: 49,595 shares on 8 July 2025 at an average price of $159.0372.
- Post-sale ownership: 1,826,382 shares held indirectly via the Administrative Trust, 2,500,000 shares held indirectly via the Survivor Trust, and 10,387 shares held directly — ≈4.34 million shares in total.
Take-aways for investors
- The disposals represent roughly 3% of the reporting person’s disclosed holdings and an immaterial <0.01% of NVIDIA’s ~2.5 billion shares outstanding.
- Because the trades were executed under a 10b5-1 plan specifically for estate-tax purposes, they are less likely to signal a change in the director’s view of the company.
- No derivative securities were exercised or disposed of; remaining derivative tables are blank.
While insider sales can raise sentiment concerns, the modest scale relative to total insider ownership and the presence of a pre-planned program temper potential negative interpretations.
Positive
- Pre-arranged 10b5-1 plan demonstrates compliance and reduces insider-information concerns.
- Director retains ≈4.34 million shares, signalling continued long-term commitment.
Negative
- 148,402 shares sold may be perceived as insider bearishness despite estate-tax rationale.
Insights
TL;DR – Small, pre-planned sale; neutral impact.
The 148 k-share disposition equals ~3 % of Seawell’s personal stake and is immaterial to NVDA’s float. Execution through a 10b5-1 plan for estate taxes reduces signaling risk. With >4.3 million shares still held, the director retains substantial alignment with shareholders. I classify the filing as routine and do not expect valuation impact.
TL;DR – Governance-friendly disclosure; minimal risk.
The form provides clear disclosure of trading-plan adoption date, price ranges, and trust structures, meeting best-practice transparency standards. Because transactions satisfy Rule 10b5-1(c) conditions and were spread over three days, the likelihood of material information misuse is low. Insider ownership remains significant, maintaining board-level skin in the game.
Insider Trade Summary
Net Seller: 148,402 shares ($23,999,797)
Net Sell
10 txns
Insider
SEAWELL A BROOKE
Role
Director
Sold
148,402 shs ($24.00M)
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| Sale | Common Stock | 22,292 | $162.3193 | $3.62M |
| Sale | Common Stock | 21,333 | $163.0789 | $3.48M |
| Sale | Common Stock | 5,506 | $163.9091 | $902K |
| Sale | Common Stock | 19,922 | $162.9602 | $3.25M |
| Sale | Common Stock | 28,199 | $163.6163 | $4.61M |
| Sale | Common Stock | 850 | $164.2981 | $140K |
| Sale | Common Stock | 49,595 | $159.0372 | $7.89M |
| Sale | Common Stock | 705 | $159.5989 | $113K |
| holding | Common Stock | -- | -- | -- |
| holding | Common Stock | -- | -- | -- |
Holdings After Transaction:
Common Stock — 1,853,221 shares (Indirect, By Administrative Trust);
Common Stock — 10,387 shares (Direct)
Footnotes (1)
- The reported transaction was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on March 19, 2025 to meet estate tax obligations. Represents weighted average sales price. The shares were sold at prices ranging from $158.480 to $159.470. The Reporting Person will provide upon request, to the Securities and Exchange Commission (the "SEC"), the Issuer or security holder of the Issuer, full information regarding the number of shares sold at each separate price. The shares are held by The Rosemary and A. Brooke Seawell Revocable Trust U/A dated 1/20/2009, of which the Reporting Person is trustee. Represents weighted average sales price. The shares were sold at prices ranging from $159.510 to $159.740. The Reporting Person will provide upon request, to the SEC, the Issuer or security holder of the Issuer, full information regarding the number of shares sold at each separate price. Represents weighted average sales price. The shares were sold at prices ranging from $162.255 to $163.250. The Reporting Person will provide upon request, to the SEC, the Issuer or security holder of the Issuer, full information regarding the number of shares sold at each separate price. Represents weighted average sales price. The shares were sold at prices ranging from $163.260 to $164.240. The Reporting Person will provide upon request, to the SEC, the Issuer or security holder of the Issuer, full information regarding the number of shares sold at each separate price. Represents weighted average sales price. The shares were sold at prices ranging from $164.260 to $164.390. The Reporting Person will provide upon request, to the SEC, the Issuer or security holder of the Issuer, full information regarding the number of shares sold at each separate price. Represents weighted average sales price. The shares were sold at prices ranging from $161.625 to $162.620. The Reporting Person will provide upon request, to the SEC, the Issuer or security holder of the Issuer, full information regarding the number of shares sold at each separate price. Represents weighted average sales price. The shares were sold at prices ranging from $162.625 to $163.620. The Reporting Person will provide upon request, to the SEC, the Issuer or security holder of the Issuer, full information regarding the number of shares sold at each separate price. Represents weighted average sales price. The shares were sold at prices ranging from $163.630 to $164.180. The Reporting Person will provide upon request, to the SEC, the Issuer or security holder of the Issuer, full information regarding the number of shares sold at each separate price. The shares are held by The Alexander Brooke Seawell Revocable Trust U/A dated 1/20/2009, of which the Reporting Person is trustee.
FAQ
What was the price range for the insider sales reported in the Form 4?
Shares were sold at weighted-average prices ranging from $158.480 to $164.390 per share.
Does the filing indicate a Rule 10b5-1 trading plan?
Yes. The transactions were executed under a Rule 10b5-1 plan adopted on 19 March 2025 to cover estate-tax obligations.
Are there any derivative securities involved in this filing?
No derivative securities were reported as acquired or disposed of; Table II is blank.